Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.
This report elaborates on the current development of the Neurodegenerative Diseases industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Teva Pharmaceutical
Addex Pharmaceutical
Boehringer Ingelheim
Pfizer
Alector
AstraZeneca
Yumanity Therapeutics
HLundbeck A/S
UCB
Biogen Idec
Bial
Yangtze River Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical
Merck Serono
Chongqing Zein Pharmaceutical
Asubio Pharmaceutical
Amarin
Eisai
Novartis
Bayer Schering Pharma AG
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
NMDA
SSRIs
Dopamine Inhibitors
Application:
Parkinson’s disease
Huntington disease
Amyotrophic Lateral Sclerosis
Alzheimer’s disease
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Neurodegenerative Diseases Industry Overview
-
1.1.1 Neurodegenerative Diseases Market Scope and Market Segments
-
1.1.2 Neurodegenerative Diseases Industry Characteristics
-
1.1.3 Global and China Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Neurodegenerative Diseases Production Value and Growth Rate (2017-2028)
-
1.2 Global Neurodegenerative Diseases Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 NMDA
-
1.2.2 SSRIs
-
1.2.3 Dopamine Inhibitors
-
1.3 Global Neurodegenerative Diseases Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Parkinson’s disease
-
1.3.2 Huntington disease
-
1.3.3 Amyotrophic Lateral Sclerosis
-
1.3.4 Alzheimer’s disease
-
1.4 Market Analysis by Region
-
1.4.1 North America Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Neurodegenerative Diseases Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Neurodegenerative Diseases Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Neurodegenerative Diseases Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Neurodegenerative Diseases Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Neurodegenerative Diseases Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Neurodegenerative Diseases Industry Porter's Five Forces Model Analysis
-
2.2.3 Neurodegenerative Diseases Industry PEST Analysis
-
2.3 Neurodegenerative Diseases Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Neurodegenerative Diseases Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Neurodegenerative Diseases Industry
Chapter 3 Global and China Neurodegenerative Diseases Market, by Manufacturer
-
3.1 Global and China Neurodegenerative Diseases Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Neurodegenerative Diseases Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Neurodegenerative Diseases Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Neurodegenerative Diseases Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Neurodegenerative Diseases Market Top 3 Players
Chapter 4 Global and China Neurodegenerative Diseases Market, by Type (2017-2028)
-
4.1 Neurodegenerative Diseases Market Trend, by Type
-
4.2 Global Neurodegenerative Diseases Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Neurodegenerative Diseases Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Neurodegenerative Diseases Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Neurodegenerative Diseases Price Trend, by Type (2017-2028)
-
4.3 China Neurodegenerative Diseases Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Neurodegenerative Diseases Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Neurodegenerative Diseases Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Neurodegenerative Diseases Price Trend, by Type (2017-2028)
Chapter 5 Global and China Neurodegenerative Diseases Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Neurodegenerative Diseases Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Neurodegenerative Diseases Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Neurodegenerative Diseases Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Neurodegenerative Diseases Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Neurodegenerative Diseases Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Neurodegenerative Diseases Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Neurodegenerative Diseases Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Neurodegenerative Diseases Market Analysis
-
7.1 North America Neurodegenerative Diseases Market, by Type
-
7.2 North America Neurodegenerative Diseases Market, by Application
-
7.3 North America Neurodegenerative Diseases Market Analysis and Forecast, by Country
-
7.3.1 United States Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Neurodegenerative Diseases Market Analysis
-
8.1 Europe Neurodegenerative Diseases Market, by Type
-
8.2 Europe Neurodegenerative Diseases Market, by Application
-
8.3 Europe Neurodegenerative Diseases Market Analysis and Forecast, by Country
-
8.3.1 Germany Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Neurodegenerative Diseases Market Analysis
-
9.1 APAC Neurodegenerative Diseases Market, by Type
-
9.2 APAC Neurodegenerative Diseases Market, by Application
-
9.3 APAC Neurodegenerative Diseases Market Analysis and Forecast, by Country
-
9.3.1 China Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Neurodegenerative Diseases Market Analysis
-
10.1 Latin America, Middle East and Africa Neurodegenerative Diseases Market, by Type
-
10.2 Latin America, Middle East and Africa Neurodegenerative Diseases Market, by Application
-
10.3 Latin America, Middle East and Africa Neurodegenerative Diseases Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Neurodegenerative Diseases Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Neurodegenerative Diseases Company Profiles
-
11.1 Teva Pharmaceutical
-
11.1.1 Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Teva Pharmaceutical Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.1.3 Teva Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Addex Pharmaceutical
-
11.2.1 Addex Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Addex Pharmaceutical Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.2.3 Addex Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Boehringer Ingelheim
-
11.3.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Boehringer Ingelheim Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.3.3 Boehringer Ingelheim Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Pfizer
-
11.4.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Pfizer Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.4.3 Pfizer Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Alector
-
11.5.1 Alector Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Alector Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.5.3 Alector Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 AstraZeneca
-
11.6.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 AstraZeneca Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.6.3 AstraZeneca Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Yumanity Therapeutics
-
11.7.1 Yumanity Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Yumanity Therapeutics Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.7.3 Yumanity Therapeutics Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 HLundbeck A/S
-
11.8.1 HLundbeck A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 HLundbeck A/S Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.8.3 HLundbeck A/S Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 UCB
-
11.9.1 UCB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 UCB Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.9.3 UCB Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Biogen Idec
-
11.10.1 Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Biogen Idec Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.10.3 Biogen Idec Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Bial
-
11.11.1 Bial Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Bial Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.11.3 Bial Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Yangtze River Pharmaceutical Group
-
11.12.1 Yangtze River Pharmaceutical Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Yangtze River Pharmaceutical Group Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.12.3 Yangtze River Pharmaceutical Group Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Jiangsu Hansoh Pharmaceutical
-
11.13.1 Jiangsu Hansoh Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.13.3 Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Merck Serono
-
11.14.1 Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Merck Serono Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.14.3 Merck Serono Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Chongqing Zein Pharmaceutical
-
11.15.1 Chongqing Zein Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Chongqing Zein Pharmaceutical Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.15.3 Chongqing Zein Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Asubio Pharmaceutical
-
11.16.1 Asubio Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Asubio Pharmaceutical Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.16.3 Asubio Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Amarin
-
11.17.1 Amarin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Amarin Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.17.3 Amarin Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Eisai
-
11.18.1 Eisai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Eisai Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.18.3 Eisai Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Novartis
-
11.19.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Novartis Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.19.3 Novartis Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.20 Bayer Schering Pharma AG
-
11.20.1 Bayer Schering Pharma AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.20.2 Bayer Schering Pharma AG Neurodegenerative Diseases Product Profiles, Application and Specification
-
11.20.3 Bayer Schering Pharma AG Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Neurodegenerative Diseases Industry Investment Prospect and Risk Assessment
-
12.1 Neurodegenerative Diseases Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Neurodegenerative Diseases Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Diseases Production Value and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Diseases Production Value and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of NMDA (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of SSRIs (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Dopamine Inhibitors (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Parkinson’s disease (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Huntington disease (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Amyotrophic Lateral Sclerosis (2017-2028)
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Alzheimer’s disease (2017-2028)
-
Figure North America Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Diseases Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Neurodegenerative Diseases Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Neurodegenerative Diseases Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Neurodegenerative Diseases Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Neurodegenerative Diseases Market Share, by Manufacturer in 2021
-
Figure Global and China Neurodegenerative Diseases Market Share, by Manufacturer in 2022
-
Table Global Neurodegenerative Diseases Sales Volume, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Figure Global Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Value, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Value Share, by Type (2017-2028)
-
Figure Global Neurodegenerative Diseases Price Trend, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Sales Volume, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Sales Value, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Sales Value Share, by Type (2017-2028)
-
Figure China Neurodegenerative Diseases Price Trend, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Volume, by Application (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure Global Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Value, by Application (2017-2028)
-
Table Global Neurodegenerative Diseases Sales Value Share, by Application (2017-2028)
-
Figure Global Neurodegenerative Diseases Sales Value Share, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Sales Volume, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Sales Value, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Sales Value Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Value Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
Figure North America Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Production, Import, Consumption and Export (2017-2022)
-
Table North America Neurodegenerative Diseases Sales Volume, by Type (2017-2028)
-
Table North America Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Figure North America Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Table North America Neurodegenerative Diseases Sales Volume, by Application (2017-2028)
-
Table North America Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure North America Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure United States Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure United States Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Canada Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Table Europe Neurodegenerative Diseases Sales Volume, by Type (2017-2028)
-
Table Europe Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Figure Europe Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Table Europe Neurodegenerative Diseases Sales Volume, by Application (2017-2028)
-
Table Europe Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure Europe Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure Germany Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure UK Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure UK Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure France Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure France Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Italy Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Spain Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Poland Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Russia Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Table APAC Neurodegenerative Diseases Sales Volume, by Type (2017-2028)
-
Table APAC Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Figure APAC Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Table APAC Neurodegenerative Diseases Sales Volume, by Application (2017-2028)
-
Table APAC Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure APAC Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Japan Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure India Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure India Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Neurodegenerative Diseases Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Neurodegenerative Diseases Sales Value and Growth Rate (2017-2028)
-
Table Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceutical Product Profiles, Application and Specification
-
Table Teva Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Addex Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Addex Pharmaceutical Product Profiles, Application and Specification
-
Table Addex Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alector Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alector Product Profiles, Application and Specification
-
Table Alector Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Yumanity Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Yumanity Therapeutics Product Profiles, Application and Specification
-
Table Yumanity Therapeutics Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table HLundbeck A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table HLundbeck A/S Product Profiles, Application and Specification
-
Table HLundbeck A/S Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table UCB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UCB Product Profiles, Application and Specification
-
Table UCB Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Idec Product Profiles, Application and Specification
-
Table Biogen Idec Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bial Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bial Product Profiles, Application and Specification
-
Table Bial Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Yangtze River Pharmaceutical Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Yangtze River Pharmaceutical Group Product Profiles, Application and Specification
-
Table Yangtze River Pharmaceutical Group Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Jiangsu Hansoh Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Jiangsu Hansoh Pharmaceutical Product Profiles, Application and Specification
-
Table Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Serono Product Profiles, Application and Specification
-
Table Merck Serono Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Chongqing Zein Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Chongqing Zein Pharmaceutical Product Profiles, Application and Specification
-
Table Chongqing Zein Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Asubio Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Asubio Pharmaceutical Product Profiles, Application and Specification
-
Table Asubio Pharmaceutical Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amarin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amarin Product Profiles, Application and Specification
-
Table Amarin Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eisai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eisai Product Profiles, Application and Specification
-
Table Eisai Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Schering Pharma AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Schering Pharma AG Product Profiles, Application and Specification
-
Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
